TD Private Client Wealth’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$973K Buy
30,922
+30,899
+134,343% +$974K 0.02% 366
2025
Q4
$664 Buy
23
+22
+2,200% +$611 ﹤0.01% 1454
2025
Q3
$14 Hold
1
﹤0.01% 1531
2025
Q2
$13 Hold
1
﹤0.01% 1401
2025
Q1
$12 Hold
1
﹤0.01% 1413
2024
Q4
$14 Sell
1
-204
-100% -$5.17K ﹤0.01% 1312
2024
Q3
$5.1K Sell
205
-766
-79% -$22.7K ﹤0.01% 1112
2024
Q2
$28.8K Buy
971
+413
+74% +$11.5K ﹤0.01% 891
2024
Q1
$16.8K Buy
+558
New +$15.5K ﹤0.01% 970
2023
Q4
Sell
-31
Closed -$1.15K 1245
2023
Q3
$1.15K Hold
31
﹤0.01% 1174
2023
Q2
$1.21K Hold
31
﹤0.01% 1198
2023
Q1
$1.13K Hold
31
﹤0.01% 1186
2022
Q4
$955 Buy
+31
New +$962 ﹤0.01% 1148

Other funds holding RTO

TD Private Client Wealth's RTO Position: Q1 2026 in Review

TD Private Client Wealth increased its Rentokil (RTO) stake by 134,343% in Q1 2026, buying an estimated $974K and bringing the position to 30,922 shares worth $973K. The position accounts for 0.02% of the portfolio, ranked #366.

TD Private Client Wealth first reported a position in RTO in Q4 2022 and has held it in 13 quarters since. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • TD Private Client Wealth held 30,922 shares of Rentokil worth $973K as of Q1 2026.
  • TD Private Client Wealth bought 30,899 Rentokil shares in Q1 2026, an estimated $974K.
  • Rentokil made up 0.02% of TD Private Client Wealth's portfolio in Q1 2026, its #366 holding.
  • TD Private Client Wealth first reported a position in Rentokil in Q4 2022 and has held it in 13 quarters since.
  • 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on TD Private Client Wealth's 13F filing for Q1 2026, filed 27 Apr 2026.